Page last updated: 2024-12-11

apigenin-7-o-beta-d-glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5319484
CHEMBL ID254213
CHEBI ID181620
SCHEMBL ID2400851
MeSH IDM0426455

Synonyms (39)

Synonym
CHEBI:181620
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxyoxane-2-carboxylic acid
29741-09-1
ACON1_001025
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-tetrahydropyran-2-carboxylic acid
4h-1-benzopyran-4-one, 7-(.beta.-d-glucopyranuronosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-
apigenin 7-o-.beta.-d-glucuronide
MEGXP0_000795
NCGC00169746-01
apigenin-7-o-betad-glucuronic acid
bdbm50241345
apigenin-7-o-beta-d-glucuronide
CHEMBL254213 ,
unii-2cq5kb3ch0
apigenin-7-o-beta-d-glucuronoside
scutellarin a
apigenin 7-o-glucuronide
apigenin 7-o-beta-d-glucuronide
apigenin 7-o-beta-d-glucuronopyranoside
beta-d-glucopyranosiduronic acid, 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl)
apigenin 7-beta-glucuronide
AKOS016011643
2cq5kb3ch0 ,
apigenin-7-glucuronide
apigenin-7-o-glucronide
SCHEMBL2400851
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-((5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl)oxy)tetrahydro-2h-pyran-2-carboxylic acid
FT-0698185
DTXSID10183893
apigenin 7-o-glucuronide, primary pharmaceutical reference standard
apigenin 7-glucuronide, >=95% (lc/ms-elsd)
benzopyran-7-yl, .beta.-d- (8ci) 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl .beta.-d-glucopyranosiduronic acid
glucopyranosiduronic acid, 5-hydroxy-2-(p-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl, .beta.-d-
F17702
CS-0016900
HY-N1454
mfcd23699539
beta-d-glucopyranosiduronic acid, 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl
BS-49735
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
flavonoidsAny organic molecular entity whose stucture is based on derivatives of a phenyl-substituted 1-phenylpropane possessing a C15 or C16 skeleton, or such a structure which is condensed with a C6-C3 lignan precursors. The term is a 'superclass' comprising all members of the classes of flavonoid, isoflavonoid, neoflavonoid, chalcones, dihydrochalcones, aurones, pterocarpan, coumestans, rotenoid, flavonolignan, homoflavonoid and flavonoid oligomers. Originally restricted to natural products, the term is also applied to synthetic compounds related to them.
glucosiduronic acidAny substance produced by linking glucuronic acid to another substance via a glycosidic bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)1.28000.00041.877310.0000AID385353
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID311505Increase in acute stress induced adrenal gland weight in Sprague-Dawley rat at 40 mg/kg, po2007Journal of natural products, Sep, Volume: 70, Issue:9
Constituents of Ocimum sanctum with antistress activity.
AID1775658Inhibition of LPS induced NO production in mouse RAW264.7 cells measured after 24 hrs by Griess reagent based assay2021Journal of natural products, 03-26, Volume: 84, Issue:3
Sesquiterpenoids from
AID1315576Inhibition of MAO in mouse brain mitochondrial fraction using kynuramine as substrate assessed as formation of 4-hydroxyquinoline by fluorescence spectrometric method2016European journal of medicinal chemistry, Oct-04, Volume: 121Antidepressant-like effects and mechanisms of flavonoids and related analogues.
AID1377663Antimicrobial activity against Candida albicans ATCC 90028 at 32 ug/ml after 24 hrs by resazurin dye based assay2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1377660Antimicrobial activity against Klebsiella pneumoniae ATCC 700603 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1516971Antifungal activity against Candida albicans after 48 hrs by broth micro dilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID385352Inhibition of advanced glycation end products formation after 14 days2008Journal of natural products, Apr, Volume: 71, Issue:4
Erigeroflavanone, a flavanone derivative from the flowers of Erigeron annuus with protein glycation and aldose reductase inhibitory activity.
AID1775659Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay2021Journal of natural products, 03-26, Volume: 84, Issue:3
Sesquiterpenoids from
AID385353Inhibition of rat lens aldose reductase2008Journal of natural products, Apr, Volume: 71, Issue:4
Erigeroflavanone, a flavanone derivative from the flowers of Erigeron annuus with protein glycation and aldose reductase inhibitory activity.
AID1377661Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1377664Antimicrobial activity against Cryptococcus neoformans ATCC 208821 at 32 ug/ml after 24 hrs by resazurin dye based assay2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1377658Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1377662Antimicrobial activity against Acinetobacter baumannii ATCC 19606 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1516972Antifungal activity against Candida parapsilosis after 48 hrs by broth micro dilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1377659Antimicrobial activity against Escherichia coli ATCC 25922 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1516973Antifungal activity against Cryptococcus neoformans after 48 hrs by broth micro dilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.78 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (33.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]